Fundraising FoxLife Biosciences
Venture capitalBoston · 7 people tracked
Find your way into Life Biosciences
392 people in our graph can introduce you to the Life Biosciences team.
Sign up to see every warm intro you have to Life Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Life Biosciences team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Life Biosciences is a venture fund manager based in Boston. SEC filings show 1 venture fund on record, most recently Life Biosciences LLC ($25M offering) filed August 2018.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 7 people
from public directoriesWhat they invest in
from 2 of 3 portfolio companiesHealthtech ×2Biotech ×1Longevity ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2025 · 12017 · 23 dated
Life Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs.
BiotechHealthtechLongevityBoston, US
David Sinclair(Director)inSharon Rosenzweig-Lipson(Chief Scientific Officer)inMichael Ringel(Chief Operating Officer)inAmit Shashank(Chief Administrative Officer & General Counsel)inAlexander Tristan Edwards(Executive Officer)Mehmood Khan(Executive Officer)in
Board seatDavid SinclairAdam NeumannBracken Darrell· per SEC Form D · $31M raise · filed Apr 2026
Co-investorsAlpha Wave GlobalPHD VenturesThe Venture CollectiveW venturesW Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesLife Biosciences · finsmes.com · Apr 8, 2026
Frequently asked questions
- Where is Life Biosciences located?
- Life Biosciences is headquartered in Boston, US.
Co-investors · 47
Founders Fund is a venture capital firm that backs technology companies building transformative products.
Craft Ventures is a venture capital firm run by a team of former founders, operators, and investors who partner closely with founders to help build and scale technology companies.
Uncork Capital is a seed-stage venture firm that backs early founders, with a focus on AI-native companies driving scale and industry change.
FJ Labs is an early-stage investment firm specializing in marketplaces and network-effect businesses, taking an angel-style co-investment approach alongside institutional venture funds worldwide.
Uber is a technology company operating multisided platforms that connect consumers with ride services, transit, delivery of food and groceries, and freight shipping across more than 70 countries and 15,000+ cities.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Plug and Play is an innovation platform that connects corporations, governments, startups, investors, and universities, running accelerator programs and venture investing across more than 25 vertical industries.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
Mayfield is a venture capital firm that invests in early-stage consumer and marketplace companies, backing founders from inception through IPO.
Precursor Ventures is a pre-seed and seed stage venture capital firm that focuses on backing founders and building long-term relationships with them from the earliest stages.
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy, partnering closely with founders on strategic and operational challenges to build global companies.
Bond is a venture capital fund spun out from Kleiner Perkins that combines Mary Meeker's famous multi-hundred-page "Trends" reports with late-stage investing, positioning itself as both a macro research house and capital provider for category-defining Internet and software businesses. The fund operates with a small, senior-heavy partnership that blends operators and growth investors, focusing on companies that have already proven product-market fit and helping them architect global expansion and IPO readiness.
▶35 more co-investors
Trajectory VenturesAbstract VenturesPoint NineNot Boring Capital01 AdvisorsDN CapitalUpfront VenturesGlobal Founders CapitalGaingelsArray Ventures Management LlcKearny JacksonPoint72 Ventures2xNCP VenturesHelium-3 VenturesRadical VenturesBoost VCAthletico VenturesFlare Capital PartnersRace CapitalBackedStrawberry Creek VenturesE1 VenturesGeek VenturesFlexcap VenturesPillar VCLigature VCTeam GlobalSprout Social, Inc.Galaxy InteractiveGolden Gate VenturesHiro CapitalMindful Venture CapitalDNA Capitali2i Ventures
Firms observed investing alongside Life Biosciences, from public investor directories. Shared companies are the overlap with Life Biosciences's recorded portfolio.